Rules Navigator

Sign in
Register

FDA launches program to bolster domestic drug manufacturing

A photo of a sign in front of the FDA headquarters.
Photo: Sarah Silbiger/Getty Images

Kevin Kinsella

 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The PreCheck program aims to make it significantly less onerous to set up domestic manufacturing plants provided they align with US national priorities.

The US Food and Drug Administration (FDA) officially launched its FDA PreCheck pilot program and is now accepting requests from drug manufacturers.

Initially announced in August, the FDA PreCheck program is designed to make it significantly less onerous to establish domestic manufacturing plants by increasing regulatory predictability, facilitating the construction

Register for free to keep reading

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free
Sign in
, , , , , ,